A novel paradigm for effective and safer treatment of schizophrenia: biased (ant)agonists with a characterized polypharmacological profile (PSYBIAS)
- J. Selent (P.I.), J.J. Meana (Principal Investigator at the University of the Basque Country / Euskal Herriko Unibertsitatea)
- from 2019 to 2021
- Financing entity:
- ERANET Neuron
Joint project with Medical Research Institute of Barcelona, Philipps- Universität Marburg and University of Montreal.